403 related articles for article (PubMed ID: 19391129)
1. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells.
Scarpino S; Di Napoli A; Taraboletti G; Cancrini A; Ruco LP
J Pathol; 2005 Jan; 205(1):50-6. PubMed ID: 15526350
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid.
Scarpino S; Stoppacciaro A; Colarossi C; Cancellario F; Marzullo A; Marchesi M; Biffoni M; Comoglio PM; Prat M; Ruco LP
J Pathol; 1999 Dec; 189(4):570-5. PubMed ID: 10629560
[TBL] [Abstract][Full Text] [Related]
4. Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells.
Scarpino S; Di Napoli A; Melotti F; Talerico C; Cancrini A; Ruco L
J Pathol; 2007 Aug; 212(4):411-9. PubMed ID: 17573672
[TBL] [Abstract][Full Text] [Related]
5. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis.
Scarpino S; D'Alena FC; Di Napoli A; Ballarini F; Prat M; Ruco LP
J Pathol; 2003 Feb; 199(2):243-50. PubMed ID: 12533838
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells.
Kanayama S; Yamada Y; Kawaguchi R; Tsuji Y; Haruta S; Kobayashi H
Oncol Rep; 2008 Jan; 19(1):117-22. PubMed ID: 18097584
[TBL] [Abstract][Full Text] [Related]
7. VEGF-C and COX-2 expression in papillary thyroid cancer.
Siironen P; Ristimäki A; Narko K; Nordling S; Louhimo J; Andersson S; Haapiainen R; Haglund C
Endocr Relat Cancer; 2006 Jun; 13(2):465-73. PubMed ID: 16728574
[TBL] [Abstract][Full Text] [Related]
8. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
9. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
10. Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.
Scarpino S; Duranti E; Giglio S; Di Napoli A; Galafate D; Del Bufalo D; Desideri M; Socciarelli F; Stoppacciaro A; Ruco L
Thyroid; 2013 Sep; 23(9):1127-37. PubMed ID: 23617728
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor expression correlates with cyclooxygenase-2 pathway in human salivary gland tumors.
Aoki T; Tsukinoki K; Kurabayashi H; Sasaki M; Yasuda M; Ota Y; Watanabe Y; Kaneko A
Oral Oncol; 2006 Jan; 42(1):51-6. PubMed ID: 16139560
[TBL] [Abstract][Full Text] [Related]
12. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
[TBL] [Abstract][Full Text] [Related]
13. Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells.
Scarpino S; Stoppacciaro A; Ballerini F; Marchesi M; Prat M; Stella MC; Sozzani S; Allavena P; Mantovani A; Ruco LP
Am J Pathol; 2000 Mar; 156(3):831-7. PubMed ID: 10702399
[TBL] [Abstract][Full Text] [Related]
14. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis.
Ruco LP; Stoppacciaro A; Ballarini F; Prat M; Scarpino S
J Pathol; 2001 May; 194(1):4-8. PubMed ID: 11329134
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
[TBL] [Abstract][Full Text] [Related]
17. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
Hall CL; Tsan R; Mugnai G; Mazar A; Radinsky R; Pettaway CA
Prostate; 2004 May; 59(2):167-76. PubMed ID: 15042617
[TBL] [Abstract][Full Text] [Related]
18. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
Nardone HC; Ziober AF; LiVolsi VA; Mandel SJ; Baloch ZW; Weber RS; Mick R; Ziober BL
Cancer; 2003 Oct; 98(7):1386-93. PubMed ID: 14508824
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells.
Welch WC; Kornblith PL; Michalopoulos GK; Petersen BE; Beedle A; Gollin SM; Goldfarb RH
Anticancer Res; 1999; 19(3A):1635-40. PubMed ID: 10470094
[TBL] [Abstract][Full Text] [Related]
20. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
Jiang Y; Xu W; Lu J; He F; Yang X
Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
